about
Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association studyGout and the risk for incident heart failure and systolic dysfunction.Chronic kidney disease as a risk factor for incident gout among men and women: retrospective cohort study using data from the Framingham Heart Study.Gout treatment and comorbidities: a retrospective cohort study in a large US managed care populationAssociation of functional polymorphism rs2231142 (Q141K) in the ABCG2 gene with serum uric acid and gout in 4 US populations: the PAGE Study.Functional polymorphisms of the ABCG2 gene are associated with gout disease in the Chinese Han male populationFacilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative studyA new approach for noninvasive transdermal determination of blood uric acid levelsChronic kidney disease in gout in a managed care settingCan racial disparities in optimal gout treatment be reduced? Evidence from a randomized trialAfrican American patients with gout: efficacy and safety of febuxostat vs allopurinol.The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age.Non-invasive and transdermal measurement of blood uric acid level in human by electroporation and reverse iontophoresisThe impact of gout on patient's lives: a study of African-American and Caucasian men and women with gout.Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout.Acute gout: oral steroids work as well as NSAIDsRacial and gender disparities among patients with gout.ABCG transporters and disease.A Pharmacist-Staffed, Virtual Gout Management Clinic for Achieving Target Serum Uric Acid Levels: A Randomized Clinical TrialGout. Novel therapies for treatment of gout and hyperuricemia.Effectiveness of a pharmacist-based gout care management programme in a large integrated health plan: results from a pilot study.Racial differences in gout incidence in a population-based cohort: Atherosclerosis Risk in Communities Study.Trends in physician diagnosed gout and gout therapies in the US: results from the national ambulatory health care surveys 1993 to 2009.Racial differences in health-related quality of life and functional ability in patients with gout.A comprehensive analysis of the association of common variants of ABCG2 with gout.Successful use of allopurinol in a patient on dialysis.Pilot study of a multidisciplinary gout patient education and monitoring program.How Can We Improve Disease Education in People with Gout?
P2860
Q24318894-F7714FC9-C6D1-4EF8-8707-CE96BA20FD28Q30505423-E224BEC7-16BE-4F93-BA8B-EE8A7BB363D3Q30930909-3E245780-7CD7-4743-A399-74C25549587BQ31013182-035BB222-9CA6-425F-9219-8984743BC507Q33621145-29EFAAA3-0D69-46F8-9A01-34395DD85E7AQ33755969-A0709369-8DC4-4E94-9A5C-F182BCE3E58DQ33766810-A9BFB6A4-2557-4AEA-A43B-08611E4AB6C2Q33857750-3A7F6694-7E19-48EC-99CB-2B973CC2CAF8Q33980619-30101F9C-3E70-47D2-AD36-3FE98ADA8DF1Q34153529-AE5EE359-994D-45BF-A70E-8A75D529335EQ34153554-97ADCA14-6FB4-4BF0-83AB-85ED81AF9A40Q34204854-7CC1A4F2-8A94-49F7-AF50-013CF8F0AA41Q34440050-C6D0A105-095C-4D9C-B2A1-4E1AA81E8180Q34502543-8607C181-7F2B-4138-A90F-0564E99450F8Q34985649-EA461634-9B96-4231-919E-3A9B5DDC9E85Q35246568-9E5BB275-C2D4-42D0-B22B-C0F68983F250Q36533940-BF5B5E60-D048-49DA-9F1A-D321556E4B5CQ37099947-5824027F-4233-4047-AA68-1BD79D8AD849Q37191351-1BF3B9D0-55AA-490E-BCAF-620A2CBAA834Q37350841-52046810-647F-4073-ABFD-767E1E23CC3CQ37516253-9EA9B49B-AC12-4910-9319-D6989B6CAC49Q37591158-5A668FF4-8B6C-42D4-B1D9-4E5F6BD29CC0Q37691042-3FD705A6-CA2F-48F0-9BEB-F4F584CA8041Q40405506-66A9054C-3BAB-49C4-B91A-E58F35635FD1Q41564015-143BEE59-87D4-4619-9BEE-31A9EC51A027Q41981175-1E969E36-E33C-49B6-940F-F0FD826A6297Q50111167-369C4761-16B5-4058-B837-015ED6E19BE2Q52667810-65DDF9B1-8BB9-4FC7-A9D9-2D275693F5A2
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Gout in ambulatory care settings in the United States.
@en
Gout in ambulatory care settings in the United States.
@nl
type
label
Gout in ambulatory care settings in the United States.
@en
Gout in ambulatory care settings in the United States.
@nl
prefLabel
Gout in ambulatory care settings in the United States.
@en
Gout in ambulatory care settings in the United States.
@nl
P2093
P1476
Gout in ambulatory care settings in the United States.
@en
P2093
C Kent Kwoh
Douglas Lienesch
Eswar Krishnan
P304
P407
P577
2008-02-01T00:00:00Z